Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Changes in Insulin Sensitivity After Weight Loss
This study is currently recruiting participants.
Verified by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), August 2008
Sponsors and Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Columbia University
Information provided by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier: NCT00627484
  Purpose

The main hypothesis of this study is that weight loss induced by gastric bypass will induce a greater improvement in insulin sensitivity compared with gastric banding or low calorie diet. Subjects will be studied before and after weight loss by intravenous glucose tolerance test and body composition will be measured by magnetic resonance imaging.


Condition Intervention
Obesity, Type 2 Diabetes Mellitus, Insulin Resistance
Procedure: gastric bypass surgery
Behavioral: Liquid Diet

MedlinePlus related topics: Diabetes Obesity Weight Control Weight Loss Surgery
Drug Information available for: Insulin
U.S. FDA Resources
Study Type: Interventional
Study Design: Basic Science, Open Label, Uncontrolled, Parallel Assignment
Official Title: Changes in Insulin Sensitivity After Weight Loss Induced by Diet or Bariatric Surgery

Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Primary Outcome Measures:
  • Insulin Sensitivity [ Time Frame: 2-8 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Body Composition [ Time Frame: 2-8 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 60
Study Start Date: August 2006
Estimated Study Completion Date: August 2010
Estimated Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Active Comparator
Gastric Bypass Surgery
Procedure: gastric bypass surgery
gastric bypass surgery
2: Active Comparator
Liquid Diet
Behavioral: Liquid Diet
Weight Loss with calorie restricted liquid diet

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • adults with or without diabetes undergoing gastric banding or gastric bypass
  • obese adults with diabetes willing to undergo weight loss with a liquid diet

Exclusion Criteria:

  • use of triglyceride lowering medication or weight loss medication
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00627484

Contacts
Contact: Gerardo Febres, MD 212-342-0281
Contact: Judith Korner, MD, PhD 212 305-3725 jk181@columbia.edu

Locations
United States, New York
Columbia University Medical Center Recruiting
New York, New York, United States, 10032
Contact: Gerardo Febres, MD     212-342-0281        
Contact: Judith Korner, MD, PhD     212 305-3725     jk181@columbia.edu    
Principal Investigator: Judith Korner, MD, PhD            
Sponsors and Collaborators
Columbia University
Investigators
Principal Investigator: Judith Korner, MD,PhD Columbia University
  More Information

Responsible Party: Columbia University ( Judith Korner, MD, PhD )
Study ID Numbers: 2401, DK072011
Study First Received: February 28, 2008
Last Updated: August 11, 2008
ClinicalTrials.gov Identifier: NCT00627484  
Health Authority: United States: Institutional Review Board

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
Insulin resistance
Insulin sensitivity
bariatric surgery
diabetes
calorie restriction
body composition

Study placed in the following topic categories:
Obesity
Metabolic Diseases
Diabetes Mellitus
Endocrine System Diseases
Overweight
Insulin
Body Weight
Signs and Symptoms
Hyperinsulinism
Diabetes Mellitus, Type 2
Weight Loss
Body Weight Changes
Nutrition Disorders
Overnutrition
Endocrinopathy
Insulin Resistance
Metabolic disorder
Glucose Metabolism Disorders

Additional relevant MeSH terms:
Hypoglycemic Agents
Physiological Effects of Drugs
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 16, 2009